- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4178 - 1,3-Diazoles not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
Patent holdings for IPC class A61K 31/4178
Total number of patents in this class: 3290
10-year publication summary
|
241
|
222
|
225
|
209
|
199
|
224
|
199
|
186
|
203
|
183
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4824 |
51 |
| Nihon Nohyaku Co., Ltd. | 332 |
48 |
| POLA Pharma Inc. | 77 |
42 |
| Vicore Pharma AB | 83 |
39 |
| Daiichi Sankyo Company, Limited | 1880 |
37 |
| Allergan, Inc. | 2315 |
32 |
| The Regents of the University of California | 20268 |
31 |
| Abbvie Inc. | 1814 |
31 |
| Achillion Pharmaceuticals, Inc. | 164 |
29 |
| F. Hoffmann-La Roche AG | 7934 |
28 |
| Gilead Sciences, Inc. | 2085 |
28 |
| Merck Sharp & Dohme LLC | 3732 |
27 |
| Theravida, Inc. | 30 |
26 |
| Janssen Pharmaceutica N.V. | 3350 |
24 |
| The Johns Hopkins University | 5752 |
23 |
| Boehringer Ingelheim International GmbH | 4637 |
22 |
| Novartis AG | 10626 |
21 |
| Acacia Pharma Limited | 40 |
19 |
| University of Virginia Patent Foundation | 1603 |
18 |
| Mayo Foundation for Medical Education and Research | 3286 |
17 |
| Other owners | 2697 |